Cargando…

Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice

SIMPLE SUMMARY: The role of the immune system in breast cancer has been debated for decades. It is generally accepted that tumor-infiltrating lymphocytes are associated with positive prognostic and predictive effects, especially in triple negative breast cancer. This subset of breast cancer is chara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Marcus, Heimes, Anne-Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507771/ https://www.ncbi.nlm.nih.gov/pubmed/34638367 http://dx.doi.org/10.3390/cancers13194883

Ejemplares similares

Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer
por: Stergiou, Natascha, et al.
Publicado: (2019)

Highlights of Immunomodulation in Salmonella-Based Cancer Therapy
por: Pangilinan, Christian R., et al.
Publicado: (2021)

Small molecule-based immunomodulators for cancer therapy
por: Wu, Yinrong, et al.
Publicado: (2022)

The Concept and Practice of Immunomodulation in Ayurveda and the Role of Rasayanas as Immunomodulators
por: Tripathi, J.S., et al.
Publicado: (1999)

Immunomodulation in Pancreatic Cancer
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2020)

Immunomodulating Nanomedicine for Cancer Therapy
por: Liu, Zhigang, et al.
Publicado: (2018)

Advances in immunomodulating therapy of HBV infection
por: Hui, Chee-Kin, et al.
Publicado: (2005)

Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization
por: Thyagarajan, Anita, et al.
Publicado: (2017)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future
por: Lecis, Dalgisio, et al.
Publicado: (2023)

Cancer-associated adipocytes as immunomodulators in cancer
por: Wu, Qi, et al.
Publicado: (2021)

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis
por: Brase, Jan C., et al.
Publicado: (2013)

Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
por: Singh, Priya, et al.
Publicado: (2021)

Schistosome immunomodulators
por: Acharya, Sreemoyee, et al.
Publicado: (2021)

Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010)

Antibody therapy: Substitution-immunomodulation -monoclonal immunotherapy
por: Mehra, Narinder K.
Publicado: (2019)

Adjunctive therapies and immunomodulating agents for severe influenza
por: Hui, David S. C., et al.
Publicado: (2013)

Mistletoe and Immunomodulation: Insights and Implications for Anticancer Therapies
por: Oei, Shiao Li, et al.
Publicado: (2019)

Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic
por: Schwab, Roxana, et al.
Publicado: (2022)

Cancer immunomodulation using bispecific aptamers
por: Thomas, Brian J., et al.
Publicado: (2022)

Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study
por: Krajnak, Slavomir, et al.
Publicado: (2023)

Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells
por: Krajnak, Slavomir, et al.
Publicado: (2023)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)

Clinical and Experimental Immunomodulation
por: Pavón, Lenin, et al.
Publicado: (2013)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke
por: Martinez, Bridget, et al.
Publicado: (2017)

Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy
por: Santos Samary, Cynthia, et al.
Publicado: (2016)

Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020)

A Review of the Role of Wnt in Cancer Immunomodulation
por: Goldsberry, Whitney N., et al.
Publicado: (2019)

The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
por: Basson, Charlise, et al.
Publicado: (2023)

Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer
por: Heimes, Anne-Sophie, et al.
Publicado: (2023)

Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
por: Peter, Hans-Hartmut, et al.
Publicado: (2020)

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
por: Ooi, Choon Jin, et al.
Publicado: (2019)

Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer
por: Heimes, Anne-Sophie, et al.
Publicado: (2022)

Immunomodulators in the Rheumatic Diseases
por: Evans, Janine
Publicado: (1991)

Immunomodulating compounds in Basidiomycetes
por: Mizuno, Masashi, et al.
Publicado: (2013)

Immunomodulators in chronic rhinosinusitis
por: Lavigne, Philippe, et al.
Publicado: (2018)

Immunomodulation in the critically ill
por: Webster, N.R., et al.
Publicado: (2009)

Immunomodulation of Skin Cancer
por: Yusuf, Nabiha
Publicado: (2023)

Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives
por: Lauruschkat, Chris D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gqjuoh77sccbthserlqtahra7i